Investigator Sponsored Trials

The mission and purpose of the Investigator Sponsored Trial program are to provide support for investigator-sponsored research (“ISTs”) in disease areas that help advance the medical and scientific knowledge of Epizyme agents.

We will accept proposals starting in January 2022. All submissions received between January 1 – May 31, 2022 will be reviewed in June, 2022. All submissions received between June 1 – November 18, 2022 will be reviewed in December, 2022.

To submit a request for further information, please download and complete this form and send to ISTgrants@epizyme.com.